Vimta Labs Ltd. — Investor Relations & Filings
Vimta Labs Ltd. is a contract research and testing organization providing comprehensive scientific services across multiple sectors. The company specializes in analytical testing, clinical research, preclinical studies, and environmental monitoring. Its service portfolio includes pharmaceutical analysis, biopharmaceutical characterization, food safety testing, and diagnostic services. Vimta operates advanced laboratory facilities equipped to handle complex regulatory requirements, including compliance with global standards such as GLP, GCP, and ISO. The organization supports the life sciences, food, and electronics industries by offering specialized services like molecular biology, microbiology, and toxicology assessments. By integrating multi-disciplinary expertise, the company facilitates product development, quality control, and safety evaluations for a global clientele.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Investor Call Transcript- FY 2025-26- Q4 Earnings/ Investor Call held on 06th May 2026 | 2026-05-12 | English | |
| Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-12 | English | |
| Copy of Newspaper Publication | 2026-05-07 | English | |
| Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-06 | English | |
| Change in Director(s) | 2026-05-06 | English | |
| Record Date | 2026-05-06 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45272164 | Investor Call Transcript- FY 2025-26- Q4 Earnings/ Investor Call held on 06th May 2026 | 2026-05-12 | English | ||
| 45261702 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-12 | English | ||
| 42965355 | Copy of Newspaper Publication | 2026-05-07 | English | ||
| 42163555 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-06 | English | ||
| 42166181 | Change in Director(s) | 2026-05-06 | English | ||
| 42171177 | Record Date | 2026-05-06 | English | ||
| 42171303 | Outcome of Board Meeting | 2026-05-06 | English | ||
| 42171271 | Dividend | 2026-05-06 | English | ||
| 42172778 | Press Release | 2026-05-06 | English | ||
| 42173852 | Investor Presentation | 2026-05-06 | English | ||
| 42174392 | Outcome of Board Meeting | 2026-05-06 | English | ||
| 42186784 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-04-29 | English | ||
| 42275161 | Board Meeting — Financial Results/Dividend | 2026-04-29 | English | ||
| 42275145 | Board Meeting — Board Meeting Intimation | 2026-04-29 | English | ||
| 42200408 | Copy of Newspaper Publication | 2026-04-28 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Urteste S.A.
Develops non-invasive urine tests for the early detection o…
|
URT | PL | Professional, scientific and te… |
|
VALIRX PLC
Life science company developing therapeutics for oncology a…
|
VAL | GB | Professional, scientific and te… |
|
Vanta Bioscience Limited
A contract research organization providing preclinical safe…
|
540729 | IN | Professional, scientific and te… |
|
Vaxil Bio Ltd.
Uses a proprietary Signal Peptide platform to develop immun…
|
VXL | CA | Professional, scientific and te… |
|
Vcanbio Cell & Gene Engineering Corp., Ltd
Focuses on stem cell bio-banking, genetic testing, and cell…
|
600645 | CN | Professional, scientific and te… |
|
VECTUS BIOSYSTEMS LIMITED
Develops therapeutics to reverse fibrosis and hypertension …
|
VBS | AU | Professional, scientific and te… |
|
Veradermics, Inc
Clinical-stage biopharmaceutical company developing medical…
|
MANE | US | Professional, scientific and te… |
|
Vera Therapeutics, Inc.
Clinical-stage biotech developing treatments for immunologi…
|
VERA | US | Professional, scientific and te… |
|
Veritas In Silico Inc.
A drug discovery company developing mRNA-targeting therapeu…
|
130A | JP | Professional, scientific and te… |
|
ViGenCell Inc.
Develops immune cell therapies to treat cancer and other in…
|
308080 | KR | Professional, scientific and te… |
Vimta Labs Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/61730/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=61730 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=61730 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=61730 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 61730}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Vimta Labs Ltd. (id: 61730)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.